Globus Medical, Inc.
US ˙ NYSE ˙ US3795772082

SecurityGMED / Globus Medical, Inc.
InstitutionSquarepoint Ops LLC
Latest Disclosed Ownership0 shares
Latest Disclosed Value $ 0
Squarepoint Ops LLC ownership in GMED / Globus Medical, Inc.

On November 14, 2025 - Squarepoint Ops LLC filed a 13F-HR form disclosing ownership of 0 shares of Globus Medical, Inc. (US:GMED) valued at $0 USD as of September 30, 2025. The entity filed a previous 13F-HR/A on August 27, 2025 disclosing 232,384 shares of Globus Medical, Inc.. This represents a change in shares of -100.00% during the quarter. The current value of the position is $0 USD.

Squarepoint Ops LLC has a history of taking positions in derivatives of the underlying security (GMED) in the form of stock options. The firm currently holds call options representing 0 of underlying shares valued at $0 USD and put options representing 0 of underlying shares valued at $0 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

GMED / Globus Medical, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2025-11-14 2025-09-30 13F GLOBUS MED CL A 379577208 0 -232,384 -100.00 0 -100.00
2025-08-27 2025-06-30 13F/A-1 GLOBUS MED CL A 379577208 232,384 203,985 718.28 13,715 560.01 0.0143
2025-08-14 2025-06-30 13F GLOBUS MED CL A 379577208 232,384 203,985 13,715 0.0143
2025-08-27 2025-03-31 13F/A-1 GLOBUS MED CL A 379577208 28,399 28,399 2,079 0.0025
2025-05-15 2025-03-31 13F GLOBUS MED CL A 379577208 28,399 28,399 2,079 0.0025
2025-02-14 2024-12-31 13F GLOBUS MED CL A 379577208 0 -27,769 -100.00 0 -100.00
2024-11-14 2024-09-30 13F GLOBUS MED CL A 379577208 27,769 6,287 29.27 1,987 35.01 0.0031
2024-08-14 2024-06-30 13F GLOBUS MED CL A 379577208 21,482 -134,319 -86.21 1,471 -82.40 0.0024
2024-05-15 2024-03-31 13F GLOBUS MED CL A 379577208 155,801 -31,795 -16.95 8,357 -16.40 0.0144
2024-02-14 2023-12-31 13F GLOBUS MED CL A 379577208 187,596 -58,798 -23.86 9,997 -18.29 0.0189
2023-11-14 2023-09-30 13F GLOBUS MED CL A 379577208 246,394 85,630 53.26 12,233 27.81 0.0302
2023-08-14 2023-06-30 13F GLOBUS MED CL A 379577208 160,764 -67,400 -29.54 9,572 -25.94 0.0293
2023-05-15 2023-03-31 13F GLOBUS MED CL A 379577208 228,164 228,164 12,923 0.0527
2023-02-14 2022-12-31 13F GLOBUS MED CL A 379577208 0 -19,660 -100.00 0 -100.00
2022-11-14 2022-09-30 13F GLOBUS MED CL A 379577208 19,660 19,660 1,171 0.0059
2022-08-15 2022-06-30 13F GLOBUS MED CL A 379577208 0 -24,015 -100.00 0 -100.00
2022-05-16 2022-03-31 13F GLOBUS MED CL A 379577208 24,015 -24,368 -50.36 1,772 -49.27 0.0076
2022-02-14 2021-12-31 13F GLOBUS MED CL A 379577208 48,383 20,079 70.94 3,493 61.04 0.0092
2021-11-15 2021-09-30 13F GLOBUS MED CL A 379577208 28,304 28,304 2,169 0.0062
2021-08-16 2021-06-30 13F GLOBUS MED CL A 379577208 0 -9,415 -100.00 0 -100.00
2021-05-17 2021-03-31 13F GLOBUS MED CL A 379577208 9,415 -29,199 -75.62 581 -76.93 0.0034
2021-02-16 2020-12-31 13F GLOBUS MED CL A 379577208 38,614 -5,770 -13.00 2,518 14.56 0.0188
2020-11-16 2020-09-30 13F GLOBUS MED CL A 379577208 44,384 -53,069 -54.46 2,198 -52.72 0.0296
2020-08-14 2020-06-30 13F GLOBUS MED CL A 379577208 97,453 97,453 119.57 4,649 111.51 0.0752
2020-05-15 2020-03-31 13F GLOBUS MED CL A 379577208 0 -90,703 -100.00 0 -100.00
2020-02-14 2019-12-31 13F GLOBUS MED CL A 379577208 90,703 78,603 649.61 5,341 762.84 0.0318
2019-11-14 2019-09-30 13F GLOBUS MED CL A 379577208 12,100 12,100 -86.66 619 -88.41 0.0055
2019-05-15 2019-03-31 13F GLOBUS MED CL A 379577208 0 -128,042 -100.00 0 -100.00
2019-02-14 2018-12-31 13F GLOBUS MED CL A 379577208 128,042 121,412 1,831.25 5,542 1,373.94 0.0645
2018-11-14 2018-09-30 13F GLOBUS MED CL A 379577208 6,630 6,630 -94.82 376 -93.22 0.0045
2018-08-14 2018-06-30 13F GLOBUS MED CL A 379577208 0 -7,397 -100.00 0 -100.00
2018-05-15 2018-03-31 13F GLOBUS MED CL A 379577208 7,397 -7,052 -48.81 369 -37.88 0.0059
2018-02-14 2017-12-31 13F GLOBUS MED CL A 379577208 14,449 -4,528 -23.86 594 5.32 0.0104
2017-11-14 2017-09-30 13F GLOBUS MED CL A 379577208 18,977 4,948 35.27 564 21.29 0.0109
2017-08-14 2017-06-30 13F GLOBUS MED CL A 379577208 14,029 -31,080 -68.90 465 -65.19 0.0091
2017-05-15 2017-03-31 13F GLOBUS MED CL A 379577208 45,109 16,926 60.06 1,336 91.13 0.0368
2017-02-14 2016-12-31 13F GLOBUS MED CL A 379577208 28,183 28,183 699 0.0286
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-15 2026-03-31 13F GLOBUS MED CL A Call 0 -100.00 0 n/a n/a n/a
2026-02-13 2025-12-31 13F GLOBUS MED CL A Call 12,000 4.35 1,048 59.12 n/a n/a n/a
2025-11-14 2025-09-30 13F GLOBUS MED CL A Call 11,500 659 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-15 2026-03-31 13F GLOBUS MED CL A Put 0 -100.00 0 n/a n/a n/a
2026-02-13 2025-12-31 13F GLOBUS MED CL A Put 3,600 314 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.